In the BioHarmony Drug Report Database
Clobazam
Onfi, Sympazan (clobazam) is a small molecule pharmaceutical. Clobazam was first approved as Onfi on 2011-10-21. It is used to treat lennox gastaut syndrome and seizures in the USA. Onfi’s patent is valid until 2024-04-03 (FDA).
Trade Name
|
Onfi, Sympazan |
|---|---|
Common Name
|
clobazam |
ChEMBL ID
|
CHEMBL70418 |
Indication
|
lennox gastaut syndrome, seizures |
Drug Class
|
Benzodiazepine |
Image (chem structure or protein)